Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma

Journal: Journal of Clinical Investigation

Published: 2020-08-20

DOI: 10.1172/jci140378

Affiliations: 18

Authors: 23

Go to article
Institutions Share
UCSF Department of Neurological Surgery, United States of America (USA) 0.43
Center for Genetic Medicine Research, Children's National Health System, United States of America (USA) 0.07
UCSF Department of Radiology and Biomedical Imaging, United States of America (USA) 0.04
Department of Pediatrics, Brown University, United States of America (USA) 0.04
Division of Hematology, Oncology, Neuro-Oncology and Stem Cell Transplantation, NU, United States of America (USA) 0.04
Dana-Farber Cancer Institute (DFCI), United States of America (USA) 0.04
Division of Hematology/Oncology, Utah, United States of America (USA) 0.04
OHSU Doernbecher Children's Hospital, United States of America (USA) 0.04
School of Medicine and Health Sciences (SMHS), GW, United States of America (USA) 0.04
Oncovir, Inc., United States of America (USA) 0.04
Parker Institute for Cancer Immunotherapy, United States of America (USA) 0.04
Department of Neurosciences, UC San Diego, United States of America (USA) 0.02
Department of Pediatrics, UC San Diego, United States of America (USA) 0.02
St. Louis Children's Hospital, United States of America (USA) 0.02
Washington University in St. Louis (WUSTL), United States of America (USA) 0.02
Center for Cancer and Immunology Research, Children's National Health System, United States of America (USA) 0.02

Return